Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,753
datasets available to search
ShareScore release 0.9.0
Dataset results
2,753 results for “NSCLC”
Anti-MUC1 CAR T Cells and PD-1 Knockout Engineered T Cells for NSCLC
ClinicalTrials.gov study NCT03525782. IPD Sharing: NO. Countries: 1. Publications: 1.
Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC
ClinicalTrials.gov study NCT02734069. IPD Sharing: NO. Countries: 1. Publications: 17.
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %
ClinicalTrials.gov study NCT04547504. IPD Sharing: YES. Countries: 1. Publications: 1.
Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC
ClinicalTrials.gov study NCT04028778. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
ClinicalTrials.gov study NCT04636775. IPD Sharing: NO. Countries: 1. Publications: 2.
Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC
ClinicalTrials.gov study NCT04140526. IPD Sharing: NO. Countries: 2. Publications: 6.
Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC
ClinicalTrials.gov study NCT01755923. IPD Sharing: Not stated. Countries: 1. Publications: 10.
A Multicenter, Single-arm, Open-label Study Evaluating the Safety and Efficacy of AK112 Combined With Chemotherapy as First-line Treatment for Non-squamous NSCLC Patients With BRAIN Metastases and Neg
ClinicalTrials.gov study NCT06684873. IPD Sharing: NO. Countries: 1. Publications: 1.
Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC
ClinicalTrials.gov study NCT02353741. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
ClinicalTrials.gov study NCT06241807. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT
ClinicalTrials.gov study NCT07037680. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases
ClinicalTrials.gov study NCT00238251. IPD Sharing: Not stated. Countries: 1. Publications: 1.
MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).
ClinicalTrials.gov study NCT02088112. IPD Sharing: YES. Countries: 3. Publications: 1.
Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00298415. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLC
ClinicalTrials.gov study NCT05236608. IPD Sharing: NO. Countries: 1. Publications: 4.
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings
ClinicalTrials.gov study NCT01700582. IPD Sharing: NO. Countries: 1. Publications: 10.
A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients
ClinicalTrials.gov study NCT05870319. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Treatment Real-world Clinical Outcomes in NSCLC
ClinicalTrials.gov study NCT05974007. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
ClinicalTrials.gov study NCT00254904. IPD Sharing: Not stated. Countries: 24. Publications: 1.
Gene Molecular Alterations as Disease Prognostic Markers in Patients With Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT06876402. IPD Sharing: NO. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.